| ²é¿´: 2976 | »Ø¸´: 12 | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß nymphWei112 µÄ 90 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á | |||
[½»Á÷]
ͶÁËplos one£¬±à¼¸ø»Ø¸´ËµÌṩÅú×¼ÄúµÄÑо¿µÄÂ×ÀíίԱ»á/IRB µÄ¾ßÌåÃû³Æ
|
|||
|
´ó¼ÒºÃ£¬ÎÒͶÁËplos one£¬ÄÚÈÝÊǶÔÅ©»§½øÐе÷Ñеõ½Êý¾Ý½øÐзÖÎöµÄ£¬ ±à¼»Ø¸´Ëµ£ºFor studies reporting research involving human participants, PLOS ONE requires authors to confirm that this specific study was reviewed and approved by an institutional review board (ethics committee) before the study began. Please provide the specific name of the ethics committee/IRB that approved your study, or explain why you did not seek approval in this case.£¨¶ÔÓÚ±¨¸æÉæ¼°ÈËÀà²ÎÓëÕßµÄÑо¿£¬PLOS ONE ÒªÇó×÷ÕßÈ·ÈϸÃÌØ¶¨Ñо¿ÔÚÑо¿¿ªÊ¼Ç°ÒÑÓÉ»ú¹¹Éó²éίԱ»á£¨Â×ÀíίԱ»á£©Éó²éºÍÅú×¼¡£ ÇëÌṩÅú×¼ÄúµÄÑо¿µÄÂ×ÀíίԱ»á/IRB µÄ¾ßÌåÃû³Æ£¬»ò½âÊÍÄúÔÚÕâÖÖÇé¿öÏÂδѰÇóÅú×¼µÄÔÒò¡££© ²»Ì«ÖªµÀÓ¦¸ÃÔõô»Ø¸´Ñ½£¬¶ÔÅ©»§µ÷ÑеÄÕâÖÖÑо¿£¬»¹ÐèÒªµÃµ½»ú¹¹Éó²éίԱ»á£¨Â×ÀíίԱ»á£©Éó²éºÍÅú×¼Â𣿠|
» ²ÂÄãϲ»¶
323Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ 070300 ѧ˶ 336·Ö Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
352Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸¶«»ª´óѧ»¯Ñ§070300£¬Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
277²ÄÁÏ¿ÆÑ§Ó빤³Ì080500Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
317Çóµ÷¼Á
ÒѾÓÐ18È˻ظ´
293Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
280·ÖÇóµ÷¼Á Ò»Ö¾Ô¸085802
ÒѾÓÐ7È˻ظ´
0854µç×ÓÐÅÏ¢Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
263Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
2026Äê¹ú»ùÇóºÃÔË£¡
+5/230
»ªÄÏÀí¹¤-¹ãÖÐÒ½ÁªºÏÕÐÊÕÉúÎïҽѧÓë²ÄÁϽ»²æÑ§¿Æ²©Ê¿Éú
+1/82
ÎÄÏ×·ÖÏí£¬»¶ÓÒýÓÃ
+1/82
¹ã¶«¹¤Òµ´óѧ-ľÖÊÏËÎ¬ËØ¸ßÖµ»¯ÀûÓÃÍŶÓÕв©Ê¿Ñо¿Éú
+1/82
Õã½´óѧºîÑô½ÌÊÚÍÅ¶Ó³ÏÆ¸²©Ê¿ºó---¸ßÐÔÄܹÌ̬µç½âÖÊÓë¹Ì̬µç³ØÆ÷¼þÉè¼Æ
+1/80
ÎÂÖÝ´óѧÂÀ¾§¾§¿ÎÌâ×é2026ÄêÕÐÉú
+1/76
ÏæÌ¶´óѧ¡°¹ý³ÌÇ¿»¯ÓëÂÌÉ«»¯¹¤¡±´´ÐÂÍŶӲ¹ÕÐ2026ÄêÇïÈëѧ²©Ê¿Éú
+1/35
Î人¸ßУ¹ú¼Ò¼¶È˲ÅÍŶÓÕÐÊÕ²ÄÁÏ£¬»¯Ñ§£¬·ÄÖ¯µÈרҵ˶ʿµ÷¼ÁÉú
+2/34
ÖÐɽ´óѧԺʿÍŶÓ΢ÄÉÆ÷¼þ¡¢ÄÔ»ú½Ó¿Ú·½Ïò²©Ê¿ÕÐÉú¡¢²©ºóÕÐÆ¸
+1/18
ºþÄÏ´óѧ΢ÉúÎï½á¹¹Ó빦ÄÜʵÑéÊÒ2026Äê¼Æ»®ÕÐÊÕ²©Ê¿Ñо¿Éú
+1/17
Õã½ÖÐÒ½Ò©´óѧ¸±Ð£³¤ÍŶÓÕÐÆ¸Ò©Ñ§/ÉúÎïÐÅϢѧµÈ·½Ïò¸ßУ½Ìʦ7Ãû£¬±¨ÃûͨµÀÒÑ¿ªÆô
+1/15
26Ä격ʿ×Ô¼ö
+1/14
ºþÄÏ´óѧ΢ÉúÎï½á¹¹Ó빦ÄÜʵÑéÊÒ2026Äê¼Æ»®ÕÐÊÕ²©Ê¿Ñо¿Éú
+1/14
ÖØÇìÎÄÀíѧԺ»¯Ñ§Óë»·¾³¹¤³ÌѧԺ 2026 ½ì˶ʿÑо¿Éúµ÷¼Á֪ͨ
+1/12
ÐÂ¼ÓÆÂ¹úÁ¢´óѧҩѧϵ»¯Ñ§ÉúÎïѧ¿ÎÌâ×éÕÐPhD
+1/10
ºþ±±´óѧ²ÄÁÏѧÕÐ26¼¶Ë¶Ê¿Ñо¿ÉúÈô¸ÉÃû
+1/6
¡¾µÚÈýÂÖÕÐÉú¡¿°Ä¿Æ´ó³ÏÕÐ2026ÄêÇï¼¾Ò©¼Áѧ˶ʿÑо¿Éú£¨3ÔÂ31ÈÕÏÂÎç18:00½ØÖ¹£©
+1/5
¹ú¼Ò¼¶È˲ÅÍÅ¶Ó³ÏÆ¸ÉúÎïÐÅÏ¢Ïà¹Ø×¨ÒµµÄ¿ÆÑÐÖúÀí
+1/4
Top-88ϤÄá¿Æ¼¼´óѧÊý¾Ý¿ÆÑ§/AI ÕÐÊÕ2027ÄêÈëѧ У½± ²©Ê¿Éú1µ½2Ãû(¹ú¼ÊºÍ±¾µØÑ§Éú£©
+1/3
MDPIÏÂIJMSͶ¸å pending editor decision 9Ìì
+1/3
¡ï
κ˧nymph(½ð±Ò+1): лл²ÎÓë
κ˧nymph(½ð±Ò+1): лл²ÎÓë
|
ÄãдÂÛÎĵÄʱºò¾Í¸ÃÔÚ²ÄÁÏ»òÊý¾ÝÀïÃæ½»´úһϣ¬ÒÑ»ñµÃÂ×ÀíÅú׼ɶµÄ ·¢×ÔСľ³æIOS¿Í»§¶Ë |
5Â¥2022-03-26 19:29:50
7Â¥2022-03-27 21:41:10
chenhuanlong
½û³æ (ÎÄѧ̩¶·)
¡ï
κ˧nymph(½ð±Ò+1): лл²ÎÓë
κ˧nymph(½ð±Ò+1): лл²ÎÓë
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
9Â¥2022-03-27 22:23:35
10Â¥2022-04-01 16:35:39
11Â¥2022-04-07 16:15:34
12Â¥2025-12-05 09:13:46
¼òµ¥»Ø¸´
tzynew2Â¥
2022-03-26 10:30
»Ø¸´
κ˧nymph(½ð±Ò+1): лл²ÎÓë
io ·¢×ÔСľ³æAndroid¿Í»§¶Ë
JeromeXu3Â¥
2022-03-26 12:52
»Ø¸´
°ØÀͼ֮Áµ4Â¥
2022-03-26 15:43
»Ø¸´
xiaoqiuqiu206Â¥
2022-03-26 19:57
»Ø¸´
κ˧nymph(½ð±Ò+1): лл²ÎÓë
shenrenren8Â¥
2022-03-27 22:13
»Ø¸´
κ˧nymph(½ð±Ò+1): лл²ÎÓë
XG-WUST13Â¥
2025-12-05 17:14
»Ø¸´
nymphWei112(½ð±Ò+1): лл²ÎÓë
up ·¢×ÔСľ³æIOS¿Í»§¶Ë













»Ø¸´´ËÂ¥